Eli Lilly has received FDA approval for an oral version of Mounjaro (tirzepatide), eliminating the need for weekly injections and potentially making the weight loss medication accessible to millions who avoid needles.
Oral Mounjaro Details
- Daily pill taken on empty stomach
- Same efficacy as injectable: 22% average weight loss
- Available in 5mg, 10mg, and 15mg doses
- Expected pharmacy availability: June 2026
- Estimated price: $1,050/month without insurance
Clinical trials showed the oral form achieved virtually identical weight loss results to the injection. Patient compliance improved significantly, with 92% adherence vs 78% for injectable.
